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Abstract: 
Background:  
Local anaesthetic thoracoscopy (LAT) is an important procedure in the management pathway of patients with 
pleural effusions, particularly those with suspected malignancy. The last survey evaluating the use and 
development of LAT services in the UK was over a decade ago.  
Objectives: 
We performed a survey of LAT practices in the UK to explore procedural preferences and variations in practice.  
Methods: 
The online survey was cascaded via regional pleural specialists to sites performing LAT.  One response per site 
was accepted.  
Results:  
37 responses were received from England, Scotland and Wales. Most centres have regular access to a dedicated 
list and a designated area to perform LAT. 97% of the centres have at least 2 trained thoracoscopists. Some 
variation in practice is seen with patient preparation pre-procedure and medication use. Other procedures such 
as insertion of indwelling pleural catheters and adhesiolysis are not uncommon to be undertaken at the time of 
LAT.      
Conclusions: 
Overall the results are comparable, excepting some minor variations in patient preparation pre-procedure.  
We hope that this survey functions as an information resource for centres developing a LAT service or for those 
considering expansion.       
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Introduction 
Local anaesthetic thoracoscopy (LAT) is an important diagnostic and therapeutic tool in the management of 
pleural effusions, especially those related to malignancy or suspected malignancy. Performed under light 
sedation, and potentially as a day case (1), LAT can provide an alternative to more invasive surgical techniques 
in some patients (2). Although national audits have reported limited data regarding UK LAT provision, (3, 4) the 
last comprehensive survey of practice took place over ten years ago (4) and thus little is known about current 
procedural preferences and practices in this area. To address this, we designed and conducted a nationwide 
survey of LAT sites, aiming to identify and characterise variances which may exist between different 
practitioners.   
 
Methods 
The survey was designed and distributed using a common online service (Google Forms, Google.Inc, California, 
USA). UK pleural specialists were initially identified and contacted by email using lists created during recent 
multicentre studies. These individuals were asked to either provide contact details for colleagues at nearby 
centres and/or to cascade the survey to others within their region if applicable. The primary pleural specialist at 
each centre was requested to complete the survey on behalf of all local LAT practitioners. Only one response 
per centre was accepted. Survey questions can be found in full in the supplementary appendix. 
 
Results 
The survey was open from 01/11/2017 to 01/12/2017. Responses were received from 37 individual sites in 
England, Scotland and Wales.  
95% of responding centres consider LAT to be their preferred method for investigating an undiagnosed pleural 
effusion. 92% of the centres had a dedicated pleural procedure list, with frequency varying from twice per week 
to ad-hoc (figure 1).  
Site and technique 
The median number of trained practitioners at each site was 2 (range 1-6), with 84% of the centres having two 
or more. A majority (76%) of centres prefer routinely admit patients overnight following a LAT. All except one 
centre practised a single port entry method, while rigid thoracoscopy the most popular technique used (31/37, 
84%). Of those remaining, 3/37 (8%) had access to both rigid and semi-rigid thoracoscopes and 3/37 (8%) used 
semi-rigid thoracoscopies exclusively. 10/37 (27%) of centres had access to on-site thoracic surgical support. The 
availability of local standardised operating procedures (SOP) for potential complications was uncommon. (see 
figure 2)  
Patient preparation 
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Most centres (33/37, 89%) preferred patients to be ‘nil by mouth’ prior to LAT, however the prescribed duration 
ranged from 2 to 12 hours. 35/37 (95%) of responders would stop Clopidogrel prior to a LAT, the majority of 
these 34/35 (97%) choosing to do so for at least five days.  
28/37 (76%) of centres do not routinely administer pre-LAT antibiotics. Where pre-procedure antibiotics were 
used, the preferred agents were Co-amoxiclav or Flucloxacillin. 
Point-of-care ultrasound was used to guide port placement in 36/37 (97%) of centres (when LAT is being 
performed for pleural effusion). If the amount of fluid was found to be minimal, 28/36 (78%) would proceed 
with the procedure following induction of a pneumothorax, with the remaining choosing to abandon the 
procedure.     
Sedation and procedure 
Combination benzodiazepine/opiate treatment was the most common practice, with intravenous midazolam 
and fentanyl (21/37, 56%) or midazolam and alfentanyl (4/37, 11%) most frequently reported. Midazolam in 
isolation was used at 5/37 (14%) centres. Four centres did not routinely use sedation.  
A majority of operators (27/37, 73%) did not routinely use intravenous fluid at the time of the procedure.  
The commonest interventions performed at the time of the LAT were adhesiolysis (26/37, 72%) and indwelling 
pleural catheter (IPC) insertion (31/37, 84%). Routine pleurodesis at the time of LAT or immediately post-
procedure was performed by 31/37 (84%) centres, the preferred method being talc poudrage (34/37, 92%). 81% 
(30/37) routinely place either a 24 French or 20 French chest tube at the end of the procedure. Post-procedure 
thoracic suction was used by 46% (17/37) of centres, either immediately post-procedure (in recovery) or after 
the patient had been moved to the ward.  
 
Discussion: 
To our knowledge, this survey represents the most up to date and complete account of any nation’s LAT practice. 
Although the survey focuses on the UK, the results are likely to be of relevance more broadly to both established 
and less-experienced LAT practitioners, providing a cross-section of how services are (and can be) delivered.  
We believe the 37 centres who responded represent the majority of those undertaking LAT in the UK (3). 
However, given that there are centres who have relatively nascent services; who will begin delivering services 
shortly; or who did not respond to the survey, we would estimate that there are as many as 50 LAT sites in the 
UK at present. The survey by Burrows et al reported 11 centres performed LAT in 1999 and that this had risen 
to 17 by 2005 (4), with the ongoing expansion in LAT provision clearly demonstrating its continuing relevance in 
modern pleural diagnostic pathways. 
These results have confirmed that there is generally good concordance in UK LAT practice. However, some 
variation appears to exist in relation to patient preparation, particularly with regards to pre-procedure 
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starvation; duration off anti-platelet agents; or the use of prophylactic antibiotics. This is perhaps unsurprising 
given the lack of robust evidence in these areas. We also note the low percentage of centres with SOPs on how 
to address potential complications. There are a number of limitations to this study. Inherent to any survey is the 
possibility of reporter bias, as well as the possibility that we were unable to identify all UK LAT sites. In addition, 
we are aware that some contacted centres who are known to undertake LAT opted not to complete the survey, 
again potentially biasing results.  
Standardisation and sharing of practices and common outcomes is important for a number of reasons, including 
delivering safe and accountable healthcare; allowing new practitioners to set targets; and setting clinical 
governance expectations for those with more experience. As such, we believe these data will help provide 
benchmarks to allow the development of more efficient, prospective approaches to LAT delivery.  
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